Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About EC
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Eukaryotic Cell
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About EC
    • For Librarians
    • For Advertisers
    • FAQ
Articles

Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae

Marcin Kolaczkowski, Anna Kolaczkowska, Barbara Gaigg, Roger Schneiter, W. Scott Moye-Rowley
Marcin Kolaczkowski
Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242Department of Biophysics, Wroclaw Medical University, 50-368 Wroclaw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Kolaczkowska
Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242Institute of Biochemistry and Molecular Biology, University of Wroclaw, 50-137 Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Gaigg
Department of Medicine, Division of Biochemistry, University of Fribourg, CH-1700 Fribourg, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Schneiter
Department of Medicine, Division of Biochemistry, University of Fribourg, CH-1700 Fribourg, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Scott Moye-Rowley
Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: moye-rowleys@physiology.uiowa.edu
DOI: 10.1128/EC.3.4.880-892.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Biosynthesis of sphingolipids in S. cerevisiae. A simplified diagram listing key steps in sphingolipid synthesis is shown. Proteins known to be involved at each step are listed by genetic designation. Gene products that are responsive to Pdr pathway regulation are indicated in bold italics.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Northern blot analysis of LAC1 and LAG1 transcription. Total RNAs were prepared from the indicated strains, electrophoresed through formaldehyde-agarose gels, and transferred to a nylon membrane. 18S RNA was visualized by staining to ensure equal loading, and LAC1 or LAG1 transcripts were detected by probing the blot with 32P-labeled DNA fragments from each coding region. (A) LAC1 mRNA levels are shown with relevant genetic backgrounds indicated. Plasmids carrying wild-type PDR1 (pPDR1), PDR3 (pPDR3), or hyperactive PDR3 (pPDR3-11) are listed along with the empty vector control (pRS315). (B) LAG1 mRNA levels are shown.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Western blot analysis of HA-tagged Lac1p and Lag1p. Whole-cell protein extracts were prepared from the indicated strains, and equal amounts of each extract were electrophoresed by SDS-PAGE. Each strain contained a low-copy-number plasmid expressing a 3× HA-tagged form of either Lac1p (top) or Lag1p (bottom). Where indicated, a low-copy-number plasmid carrying hyperactive PDR3 (PDR3-11) or the empty vector (pRS315) was also present. After electrophoresis, the proteins were transferred to nitrocellulose and the membrane was probed with an anti-HA antibody. A monoclonal antibody directed against the vacuolar membrane protein Vph1p was used to ensure equal loading and transfer.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    A single PDRE mediates Pdr pathway regulation of LAC1. Low-copy-number plasmids carrying either a wild-type LAC1 promoter fusion to lacZ (LAC1-lacZ) or a mutant promoter lacking the PDRE (mPDRE-LAC1-lacZ) were introduced into the strains listed at the bottom of the figure (relevant genetic markers are shown). An empty vector plasmid (pRS315) or the same vector carrying the hyperactive PDR3-11 allele were present where indicated. Transformants were grown to mid-log phase, and β-galactosidase activities were determined as described in Materials and Methods.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Pdr1p and Pdr3p bind to LAC1 PDRE in vitro. DNA fragments containing the PDRE region from either the wild-type LAC1 promoter (wt) or the site-directed mutant form (mPDRE) were radiolabeled with 32P as described in Materials and Methods. Each probe was incubated with no added proteins, with protein extracts from bacterial cells carrying an empty expression vector (vector only), or with the same vector expressing the DNA binding domain of Pdr1p or Pdr3p. Protein-DNA complexes were then treated with DNase I followed by electrophoresis through denaturing acrylamide-urea gels as described previously (32). The location of the PDRE (indicated to the left) was determined by comparison to a Maxam-Gilbert chemical cleavage reaction and restriction digestion (not shown).

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Deletion mapping of the LAC1 promoter. A series of 5′ and internal promoter deletion derivatives of the LAC1-lacZ plasmid were generated. The solid lines indicate the extent of the promoter that remains in each construct. The name of each mutant construct is shown on the left side of the figure. A line drawing of the wild-type LAC1 promoter region is shown at the top with numbers referring to distances from the ATG codon. The dark gray boxes show the location of the putative Cbf1p binding sites, the white box corresponds to the PDRE, and the light gray box denotes the Rox1p binding site. The PDRE was altered by a site-directed mutation in pMK010303 and was precisely deleted from pMK0104-4. Each plasmid was transformed into isogenic wild-type (BY4742) or rox1Δ (BY4742 rox1Δ) cells, and β-galactosidase activities were assayed as described in the text.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Recombinant Rox1p binds to an element in the LAC1 promoter. DNase I protection analysis was used as described in the text. A purine-specific chemical cleavage reaction (AG) was used to locate the Rox1p binding site (shown to the left). DNase I digestion was carried out in the absence of added protein (no protein) or with increasing amounts of Rox1p (indicated at the top).

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    LAC1 and LAG1 expression control by Cbf1p and Rox1p. Low-copy-number plasmids containing the lacZ fusion genes listed were introduced into the indicated isogenic strains. Transformants were grown to mid-log phase and β-galactosidase activities were determined. (A) Expression of LAC1-lacZ fusion plasmids plotted on the same scale for comparison. (B) Expression of LAG1-lacZ plotted on an expanded scale to emphasize the observed change in gene expression.

  • FIG. 9.
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    LCB2 and SUR2 response to elevated Pdr pathway activity and rox1Δ. LCB2-lacZ and SUR2-lacZ fusions carried on low-copy-number plasmids were introduced into isogenic wild-type or rox1Δ strains along with an empty vector (pRS315) or the same plasmid carrying the hyperactive PDR3-11 allele. Transformants were grown and assayed for β-galactosidase activity as described in the text.

  • FIG. 10.
    • Open in new tab
    • Download powerpoint
    FIG. 10.

    Pdr-dependent changes in sphingolipid and ceramide composition. Cells of the indicated genotype expressing either PDR3 or the hyperactive PDR3-11 allele were labeled with [3H]serine for 2 h at 30°C, lipids were extracted and deacylated, and sphingolipids and ceramides were analyzed by thin-layer chromatography. Mol% values for the indicated lipid species are indicated on the ordinate. (A) Relative abundance of IPC-C and IPC-D species; (B) composition of free ceramide species.

Tables

  • Figures
  • TABLE 1.

    S. cerevisiae strains used for this study

    StrainGenotypeSource or reference
    BY4742MATα his3-Δ1 leu2-Δ0 lys2-Δ0 ura3-Δ0Research Genetics
    BY4742 Δrox1BY4742 rox1-Δ::kanMX4Research Genetics
    BY4742 Δlac1BY4742 lac1-Δ::kanMX4Research Genetics
    BY4742 Δcbf1BY4742 cbf1-Δ::kanMX4Research Genetics
    SEY6210MATα leu2-3,-112 ura3-52 lys2-801 trp1-Δ901 his3-Δ200 suc2-Δ9 Mel−Scott Emr
    SEY6210 ρ0SEY6210 [ρ0]47
    SEY6210 Δpdr1SEY6210 pdr1-Δ2::hisG47
    SEY6210 Δpdr3SEY6210 pdr3-Δ1::hisG47
    SEY6210 Δpdr1 Δpdr3SEY6210 pdr1-Δ2::hisG pdr3-Δ1::hisG47
    SEY6210 ρ0 Δpdr1SEY6210 [ρ0] pdr1-Δ2::hisG47
    SEY6210 ρ0 Δpdr3SEY6210 [ρ0] pdr3-Δ1::hisG47
    SEY6210 ρ0 Δpdr1 Δpdr3SEY6210 [ρ0] pdr1-Δ2::hisG pdr3-Δ1::hisG47
    MK0201-2SEY6210 lac1-Δ::kanMX4This study
    MK0112-1SEY6210 mPDRE-LAC1This study
    MK0220-22SEY6210 lag1-Δ::dpl200This study
    MK0228-7-2SEY6210 lag1-Δ::dpl200 mPDRE-LAC1This study
    MK0211-1SEY6210 [ρ0] lac1-Δ::kanMX4This study
    MK0221-2SEY6210 [ρ0] lag1-Δ::dpl200This study
PreviousNext
Back to top
Download PDF
Citation Tools
Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
Marcin Kolaczkowski, Anna Kolaczkowska, Barbara Gaigg, Roger Schneiter, W. Scott Moye-Rowley
Eukaryotic Cell Aug 2004, 3 (4) 880-892; DOI: 10.1128/EC.3.4.880-892.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Eukaryotic Cell article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
(Your Name) has forwarded a page to you from Eukaryotic Cell
(Your Name) thought you would be interested in this article in Eukaryotic Cell.
Share
Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
Marcin Kolaczkowski, Anna Kolaczkowska, Barbara Gaigg, Roger Schneiter, W. Scott Moye-Rowley
Eukaryotic Cell Aug 2004, 3 (4) 880-892; DOI: 10.1128/EC.3.4.880-892.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About EC
  • For the Media
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1535-9778; Online ISSN: 1535-9786